Literature DB >> 33475761

Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Alexis Moscoso1,2, Michel J Grothe3,4,5,6, Michael Schöll7,8,9.   

Abstract

PURPOSE: Recent research has suggested the use of white matter (WM) reference regions for longitudinal tau-PET imaging. However, tau tracers display affinity for the β-sheet structure formed by myelin, and thus WM lesions might influence tracer retention. Here, we explored whether the tau-sensitive tracer [18F]flortaucipir shows reduced retention in WM hyperintensities (WMH) and how this retention changes over time.
METHODS: We included 707 participants from the Alzheimer's Disease Neuroimaging Initiative with available [18F]flortaucipir-PET and structural and FLAIR MRI scans. WM segments and WMH were automatically delineated in the structural MRI and FLAIR scans, respectively. [18F]flortaucipir standardized uptake value ratios (SUVR) of WMH and normal-appearing WM (NAWM) were calculated using the inferior cerebellar grey matter as reference region, and a 3-mm erosion was applied to the combined NAWM and WMH masks to avoid partial volume effects. Longitudinal [18F]flortaucipir SUVR changes in NAWM and WMH were estimated using linear mixed models. The percent variance of WM-referenced cortical [18F]flortaucipir SUVRs explained by longitudinal changes in the WM reference region was estimated with the R2 coefficient.
RESULTS: Compared to NAWM, WMH areas displayed significantly reduced [18F]flortaucipir SUVR, independent of cognitive impairment or Aβ status (mean difference = 0.14 SUVR, p < 0.001). Older age was associated with lower [18F]flortaucipir SUVR in both NAWM (- 0.002 SUVR/year, p = 0.005) and WMH (- 0.004 SUVR/year, p < 0.001). Longitudinally, [18F]flortaucipir SUVR decreased in NAWM (- 0.008 SUVR/year, p = 0.03) and even more so in WMH (- 0.02 SUVR/year, p < 0.001). Between 17% and 66% of the variance of longitudinal changes in cortical WM-referenced [18F]flortaucipir SUVRs were explained by longitudinal changes in the reference region.
CONCLUSIONS: [18F]flortaucipir retention in the WM decreases over time and is influenced by the presence of WMH, supporting the hypothesis that [18F]flortaucipir retention in the WM is partially myelin-dependent. These findings have implications for the use of WM reference regions for [18F]flortaucipir-PET imaging.

Entities:  

Keywords:  Hyperintensity; Longitudinal; Myelin; Reference region; Tau PET; White matter

Year:  2021        PMID: 33475761     DOI: 10.1007/s00259-021-05195-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  56 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

2.  Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.

Authors:  Ruben Smith; Moa Wibom; Daria Pawlik; Elisabet Englund; Oskar Hansson
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

Review 3.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

4.  Tau-positron emission tomography correlates with neuropathology findings.

Authors:  Val J Lowe; Emily S Lundt; Sabrina M Albertson; Hoon-Ki Min; Ping Fang; Scott A Przybelski; Matthew L Senjem; Christopher G Schwarz; Kejal Kantarci; Bradley Boeve; David T Jones; R Ross Reichard; Jessica F Tranovich; Fadi S Hanna Al-Shaikh; David S Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2020-01-04       Impact factor: 21.566

5.  Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.

Authors:  Val J Lowe; Tyler J Bruinsma; Heather J Wiste; Hoon-Ki Min; Stephen D Weigand; Ping Fang; Matthew L Senjem; Terry M Therneau; Bradley F Boeve; Keith A Josephs; Mukesh K Pandey; Melissa E Murray; Kejal Kantarci; David T Jones; Prashanthi Vemuri; Jonathan Graff-Radford; Christopher G Schwarz; Mary M Machulda; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  Neurology       Date:  2019-05-30       Impact factor: 9.910

6.  Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.

Authors:  Andrew J Aschenbrenner; Brian A Gordon; Tammie L S Benzinger; John C Morris; Jason J Hassenstab
Journal:  Neurology       Date:  2018-08-01       Impact factor: 9.910

7.  Why has therapy development for dementia failed in the last two decades?

Authors:  Serge Gauthier; Marilyn Albert; Nick Fox; Michel Goedert; Miia Kivipelto; Jorge Mestre-Ferrandiz; Lefkos T Middleton
Journal:  Alzheimers Dement       Date:  2015-12-19       Impact factor: 21.566

8.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

9.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.

Authors:  Matthew R Brier; Brian Gordon; Karl Friedrichsen; John McCarthy; Ari Stern; Jon Christensen; Christopher Owen; Patricia Aldea; Yi Su; Jason Hassenstab; Nigel J Cairns; David M Holtzman; Anne M Fagan; John C Morris; Tammie L S Benzinger; Beau M Ances
Journal:  Sci Transl Med       Date:  2016-05-11       Impact factor: 17.956

10.  Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.

Authors:  Rik Ossenkoppele; Ruben Smith; Tomas Ohlsson; Olof Strandberg; Niklas Mattsson; Philip S Insel; Sebastian Palmqvist; Oskar Hansson
Journal:  Neurology       Date:  2019-01-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.